Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$427K Sell
23,497
-16,631
-41% -$282K ﹤0.01% 995
2026
Q1
$548K Buy
+40,128
New +$440K ﹤0.01% 797
2024
Q3
Sell
-16,126
Closed -$159K 2372
2024
Q2
$159K Buy
+16,126
New +$172K ﹤0.01% 1755

Other funds holding INTT

Centiva Capital's INTT Position: Q2 2026 in Review

Centiva Capital reduced its inTEST (INTT) stake by 41% in Q2 2026, selling an estimated $282K and leaving 23,497 shares worth $427K. The position accounts for ﹤0.01% of the portfolio, ranked #995.

Centiva Capital first reported a position in INTT in Q2 2024 and has held it in 3 quarters since. The position peaked at $548K in Q1 2026. 90 funds tracked by Wall St. Rank hold INTT as of Q2 2026.

  • Centiva Capital held 23,497 shares of inTEST worth $427K as of Q2 2026.
  • Centiva Capital sold 16,631 inTEST shares in Q2 2026, an estimated $282K.
  • inTEST made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #995 holding.
  • Centiva Capital first reported a position in inTEST in Q2 2024 and has held it in 3 quarters since.
  • Centiva Capital's inTEST position peaked at $548K in Q1 2026.
  • 90 funds tracked by Wall St. Rank held inTEST as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.